ProMIS Neurosciences to Participate in Upcoming Conferences in June
ProMIS Neurosciences will participate in several major healthcare conferences in June 2026, including presentations at the Jefferies Global Healthcare Conference and Wolfe Research’s Virtual Alzheimer’s R&D Day. CEO Neil Warma will discuss the company’s EpiSelect platform and lead Alzheimer’s candidate PMN310, which targets toxic amyloid-beta oligomers.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.